Research & KnowledgeEvent: September 8, 2026
MiMedx published a retrospective, multicenter study in the European Surgical Research Journal evaluating 30-day outcomes in complicated diverticulitis patients receiving AMNIOFIX as a protective barrier after colectomy anastomosis, referencing the ACS-NSQIP national database.
Published
Signal category
Research & Knowledge
Quote
“A retrospective, multicenter study published in the European Surgical Research Journal¹ evaluated 30-day outcomes in complicated diverticulitis patients receiving AMNIOFIX® as a protective barrier after colectomy anastomosis”
— MiMedx team
Company
- Industry
- Medical Equipment Manufacturing
- Location
- Marietta, US
- Company size
- 763 employees
MIMEDX is a pioneer and leader in the field of placental tissue. With more than a decade of helping clinicians manage chronic and hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical settings of healthcare. The Company's vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life.
Founded 2008